TrialCardiovascular diabetology2023

Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial.

Reza Mohebi et al.PubMed ↗Full text ↗Publisher ↗

A secondary analysis of NCT02065791. The trial’s primary report, PMID 30990260, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.